Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE)

Autor: Ambrosy, Andrew P., Malik, Umar I., Thomas, Rachel C., Parikh, Rishi V., Tan, Thida C., Goh, Choon H., Selby, Van N., Solomon, Matthew D., Avula, Harshith R., Fitzpatrick, Jesse K., Skarbinski, Jacek, Philip, Sephy, Granowitz, Craig, Bhatt, Deepak L., Go, Alan S.
Zdroj: In American Heart Journal May 2021 235:54-64
Databáze: ScienceDirect
Externí odkaz: